Boston Scientific Corp said on Thursday it was recalling its Lotus range of heart devices, citing reports of problems with the locking mechanism, sending its shares down 7.3 percent in morning trading.
The products are expected to return to the European market and other regions in the fourth quarter, the company said, noting the issue was caused by excess tension in the pin mechanism introduced during the manufacturing process.
The company’s Lotus technology is used in transcatheter aortic valve replacement (TAVR), a minimally invasive procedure designed to replace a narrowed aortic valve that fails to open properly.
